EN DE
Watch Valiant Organics Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Valiant Organics Limited (VALIANTORG) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Valiant Organics Limited stock ₹294, price ₹346, that is 14.9% below the price, quality 57 out of 100. Rating: overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE565V01010

VO Valiant Organics Limited logo Broad data Nov 12, 2026

Valiant Organics Limited

VALIANTORG · NSE

Expensive (fair value 15% below the price), but solid company and rising price: meets 2 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Low debt 
Generates free cash flow 
Broad data 
Quality 57/100 
Thin margins · 7.1% net margin (TTM) 
Mixed vs. peers (6/13) 
Fair value ₹294.33 · Overvalued 
Weak Growth (revenue 5y −0.4 %/yr in INR) 
Narrow moat 40/100 · thin data
⟳ Cyclical
Watch Valiant Organics Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹1,598 ₹197.64 Fair Value ₹294.33 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range ₹197.64 – ₹1,598 · fair‑value band ₹165.05 – ₹392.93 · the ₹345.70 price screens above the ₹294.33 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 12, 2026.

Follow Valiant Organics in your weekly email

Every Wednesday you see whether Valiant Organics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India and internationally.

Show moreShow less

The company offers para chloro phenol; ortho chloro phenol; 2,4 di chloro phenol; 2,4,6 tri chloro phenol; n-isopropyl para chloro aniline; meta chloro aniline; para flouro aniline; 4-flouro-N-isopropylaniline; 2,4-dichlorophenoxyacetic acid; para nitro aniline; ortho chloro para nitro aniline; ortho anisidine; para anisidine; ortho toluidine 5 sulfonic acid; 6 acetyl oapsa; ortho nitro aniline para sulphonic acid; ortho amino phenol; 4B and 2B acid; 2,6 di chloro phenol; and para"amino phenol.

It also provides IPPCA, OA/PA acetanilide, OT5SA, ortho nitro anisole, and para nitro anisole. The company's products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs.

It exports its products to Asia, Europe, and the United States. Valiant Organics Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Stock analysis

Valiant Organics Limited (VALIANTORG) currently trades at ₹345.70, while our model-based Fair Value estimate is ₹294.33, 15% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of ₹303.53 per share, and 4 of the 24 models we run sit above the ₹345.70 price.

Bear case: the Economic Profit group reads lowest at ₹125.37, and 20 of the 24 models stay below the price. Data coverage for this calculation is high.

Scenario range: ₹165.05 (bear) to ₹392.93 (bull), the price of ₹345.70 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 57/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Valiant Organics Limited reported revenue of ₹7.4B in FY2026 versus ₹11.5B in FY2022, a compound −10.5%/yr. Reported net income was ₹332M in FY2026, compounding −26.4%/yr from FY2022.

Key figures

Market cap ₹9.7B (≈ $103M) Micro · P/E ratio 17.8 · P/S ratio 1.33 · EPS (TTM) ₹19.37 · Net margin 7.1% · Return on equity 4.5% · Return on assets (EBIT) 6.4% (5-year average) · Operating margin 13.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (low confidence).

What moves the price

The share trades about 30% below its 52-week high and 75% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −29% fair-value upside, at −15%, VALIANTORG screens cheaper than that median.

Fair Value models

Bear ₹165.05 Fair Value ₹294.33 Bull ₹392.93
Price ₹345.70 · Downside -14.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹12.21 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹193.01 ₹284.75 ₹516.22 78
Growth DCF ₹181.83 ₹295.79 ₹479.94 77
EPV ₹74.72 ₹84.76 ₹92.76 74
All 24 models by family
DCF Models
FCF DCF ₹193.01 ₹284.75 ₹516.22 78
Owner Earnings ₹151.56 ₹301.90 ₹553.37 73
5Y Revenue Exit ₹160.89 ₹289.66 ₹537.76 69
5Y EBITDA Exit ₹199.06 ₹371.76 ₹685.99 72
5Y P/E Exit ₹150.65 ₹293.63 ₹472.39 69
10Y Revenue Exit ₹165.05 ₹309.98 ₹465.14 65
10Y EBITDA Exit ₹191.02 ₹368.39 ₹681.34 65
10Y P/E Exit ₹163.46 ₹294.33 ₹506.30 61
Earnings-Based
Graham-Dodd ₹80.62 ₹562.20 ₹788.97 63
Lynch FV ₹169.38 ₹241.97 ₹314.56 61
PEG = 1.0 ₹169.38 ₹241.97 ₹314.56 57
EPV ₹74.72 ₹84.76 ₹92.76 74
Multiples
P/E Multiple ₹151.15 ₹201.54 ₹251.92 63
P/S Multiple ₹151.15 ₹201.54 ₹251.92 58
P/B Multiple ₹318.14 ₹424.19 ₹530.23 55
EV/EBIT ₹91.56 ₹152.25 ₹212.94 64
EV/EBITDA ₹145.38 ₹224.02 ₹302.65 66
EV/Revenue ₹67.28 ₹134.91 ₹202.53 51
Asset-Based
NCAV (Graham) ₹133.18 ₹178.46 ₹266.35 54
Growth DCF
Growth DCF ₹181.83 ₹295.79 ₹479.94 77
Rev-Margin DCF ₹160.89 ₹311.26 ₹535.37 70
Economic Profit
Residual Income ₹165.59 ₹165.97 ₹175.86 71
ROIC Compounder ₹74.72 ₹84.76 ₹92.76 72
Growth Earnings
Growth-Adj P/E ₹211.58 ₹302.26 ₹392.93 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 57/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 32
How much profit the company makes from its sales and capital
Quality Growth 47
Are margins and returns getting better?
Cashflow 54
Do the profits arrive as real cash?
Financial strength 55
Debt, balance sheet and risk of trouble
Investment 90
Does it invest with discipline instead of growing at any price?
Low Volatility 51
How calm the share price moves, does not count
Price momentum 69
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 52
Distance to the 52-week high, does not count
New shares 74
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+2.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.4%
Start year 2021 (pandemic). Over 10 years: +30.4% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.9%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−22.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−22.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−22.0% vs 1.7%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 7%
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+25.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +20.7% a year for the price.

VALIANTORG screens overvalued: fair value 15% below the price. Compare with BASF SE →

Compare Valiant Organics Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 358 stocks

Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 57 · Above median
Fair Value upside −18.8% · Below median
Profitability
Return on equity (12 months) 4.5% · Below median
Return on assets 2.7% · Above median
Net margin (12 months) 7.1% · Above median
Operating margin (12 months) 13.6% · Above median
Growth and dividend
Revenue growth (quarter YoY) 13.3% · Below median
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Chemicals median · lower = cheaper

P/E (12 months) 17.8× · Cheaper than median
P/B 1.34× · Cheaper than median
P/S (12 months) 1.33× · Pricier than median
Price / free cash flow (fiscal year) 23.1× · Pricier than median
EV/EBITDA 10.1× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)8 · sector 10
FUTURE (revenue growth)67 · sector 73
PAST (return on equity)18 · sector 24
HEALTH (low debt)97 · sector 94
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Valiant Organics Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Valiant Organics Limited Fair Value". https://www.fairvalue-calculator.com/stock/VALIANTORG

Frequently asked questions

Is Valiant Organics Limited (VALIANTORG) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of ₹294.33 versus a price of ₹345.70, about 15% lower (overvalued).
What is the fair value of VALIANTORG?
Our model-based fair value for Valiant Organics Limited is ₹294.33 (as of Nov 12, 2026), built from audited fundamentals. The current price: ₹345.70.
What is the quality score of VALIANTORG?
Valiant Organics Limited has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Valiant Organics Limited (VALIANTORG)?
Our model-based price target is the fair value of ₹294.33 (as of Nov 12, 2026) from 24 valuation models. Cautious scenario ₹165.05, optimistic scenario ₹392.93. It is a calculation from audited fundamentals, not an analyst target.
What is the Valiant Organics Limited stock forecast for 2026?
Our models put fair value at ₹294.33, about 15% lower versus a price of ₹345.70 (overvalued). Cautious scenario ₹165.05, optimistic scenario ₹392.93. The calculation is refreshed regularly with new filings.
What is the revenue of Valiant Organics Limited (VALIANTORG)?
Valiant Organics Limited reported trailing-twelve-month revenue of about ₹7.7B (latest available figure, as of Nov 12, 2026).
What growth is priced into Valiant Organics Limited (VALIANTORG)?
For today's price to be fair in a discounted-cash-flow model, Valiant Organics Limited would have to grow free cash flow by 25.6 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue fell 0.4 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of VALIANTORG use?
Our models discount Valiant Organics Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.43, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Valiant Organics Limited that is +25.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Valiant Organics Limited (VALIANTORG) delivered so far?
Over the past 5 years revenue at Valiant Organics Limited shrank 0.4 % a year. The price currently implies free-cash-flow growth of +25.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Valiant Organics Limited (VALIANTORG) growing?
The median revenue growth in the sector is +11.6 % a year. That is the yardstick for the growth priced into Valiant Organics Limited (+25.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Valiant Organics Limited (VALIANTORG)?
The free-cash-flow yield on the price is 4.53 %: that much free cash flow Valiant Organics Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Valiant Organics Limited (VALIANTORG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Valiant Organics Limited it is ₹294.33 per share (as of Nov 12, 2026), against a price of ₹345.70. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Valiant Organics Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, VALIANTORG trades above its calculated fair value: price ₹345.70, fair value ₹294.33, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VALIANTORG?
No. The price is what the market pays today (₹345.70); the fair value is what the company's own numbers justify (₹294.33). For Valiant Organics Limited the two are ₹51.37 per share apart. That gap is exactly why we show both numbers side by side.
How much is Valiant Organics Limited worth?
The market values Valiant Organics Limited at about ₹9.7B (market capitalisation, as of Nov 12, 2026). Per share that is ₹345.70; our models calculate a fair value of ₹294.33 per share.
What do the bullish and bearish scenarios say about VALIANTORG?
Our models span a range for Valiant Organics Limited: cautious scenario ₹165.05, base ₹294.33, optimistic ₹392.93 per share (as of Nov 12, 2026, price ₹345.70). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of VALIANTORG?
Valiant Organics Limited trades at a price-to-earnings ratio of 17.8 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹294.33 is built from several models across several years. Other multiples: P/B 1.3, P/S 1.3, EV/EBITDA 10.1.
How solid is the balance sheet of Valiant Organics Limited (VALIANTORG)?
Balance-sheet figures for Valiant Organics Limited (as of Nov 12, 2026): return on equity 4.5%, debt of 0.07 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is VALIANTORG from its 52-week high?
Valiant Organics Limited trades at ₹345.70, about 30% below its 52-week high of ₹496.80 and 75% above the low of ₹197.64 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ₹294.33 is for.
Which stocks are comparable to Valiant Organics Limited?
From the same area (Basic Materials) we also value BASF SE, Dow Inc, Ningxia Baofeng Energy Group, Rongsheng Petrochemical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Valiant Organics Limited stock attractive at the current price?
The data as of Nov 12, 2026: price ₹345.70, calculated fair value ₹294.33 (−15%), Quality Score 57/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VALIANTORG calculated?
We run Valiant Organics Limited through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹294.33 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Valiant Organics Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Valiant Organics Limited (VALIANTORG)?
The closing price on Nov 16, 2026 was ₹345.70. Our model-based fair value is ₹294.33, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Valiant Organics Limited right now?
Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹165.05 to ₹392.93) leaves room in how you read the outcome.

Key figures of Valiant Organics Limited

How large is the market capitalisation of Valiant Organics Limited (VALIANTORG)?
The market capitalisation of Valiant Organics Limited is ₹9.7B (≈ $103M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Valiant Organics Limited (VALIANTORG)?
The price-to-sales ratio of Valiant Organics Limited is 1.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Valiant Organics Limited (VALIANTORG)?
Earnings per share at Valiant Organics Limited are ₹19.37 (price ÷ EPS = P/E 17.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Valiant Organics Limited (VALIANTORG)?
The net margin of Valiant Organics Limited is 7.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Valiant Organics Limited (VALIANTORG)?
The return on equity (ROE) of Valiant Organics Limited is 4.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Valiant Organics Limited (VALIANTORG)?
On an EBIT basis the return on assets of Valiant Organics Limited is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Valiant Organics Limited (VALIANTORG)?
The operating margin of Valiant Organics Limited is 13.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Valiant Organics Limited (VALIANTORG)?
Revenue at Valiant Organics Limited is growing 13.3% versus a year earlier (3y avg −11.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Valiant Organics Limited (VALIANTORG)?
Earnings per share at Valiant Organics Limited are growing 256% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Valiant Organics Limited (VALIANTORG) carry?
The net debt of Valiant Organics Limited is ₹2.5B (fiscal year 2026, ≈ 5.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Valiant Organics Limited in the live analysis

One click puts Valiant Organics Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.